Cero Therapeutics Holdings, Inc. (CERO): Dividends Paid

Annual figures by period end, from SEC filings.

$127.1K

Year ended 2025-12-31

Period ended	Dividends Paid	Change YoY	Source filing
2025-12-31	$127.1K	n/a	2026-04-15, From 2025-01-01

Dividends Paid at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Dividends Paid	Change YoY
Cero Therapeutics Holdings, Inc. (CERO)	2025-12-31	$127.1K	n/a
Windtree Therapeutics Inc (WINT)	2024-12-31	$657.0K	n/a
Viskase Holdings, Inc. (VISK)	2025-12-31	$1.27M	0.0%
Scilex Holding Co (SCLX)	2024-12-31	$8.65M	0.0%
Monte Rosa Therapeutics, Inc. (GLUE)	2025-12-31	$0	n/a
Vor Biopharma Inc. (VOR)	2025-12-31	$0	n/a
Bio-Techne Corp (TECH)	2026-06-30	$49.92M	-0.9%
Qiagen N.V. (QGEN)	2025-12-31	$54.24M	n/a
Gilead Sciences, Inc. (GILD)	2025-12-31	$4.00B	+2.2%

Compare CERO, WINT, VISK, SCLX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗